畜牧兽医学报 ›› 2006, Vol. 37 ›› Issue (1): 50-55.

• 预防兽医 • 上一篇    下一篇

犬瘟热病毒H、F、N基因试验免疫研究

闫 芳; 夏咸柱;扈荣良;谢之景;赵忠鹏;高玉伟;黄 耕   

  1. 1.解放军军需大学军事兽医研究所,长春 130062; 2.山西农业大学动物科技学院,太谷 030801;3.山东农业大学动科院,泰安 271018
  • 收稿日期:1900-01-01 修回日期:1900-01-01 出版日期:2006-01-25 发布日期:2006-01-25

Experimental Study on Immunity of Canine Distemper Virus Structural Protein Gene H,F and N

YAN Fang; XIA Xian-zhu;HU Rong-liang; XIE Zhi-jing;ZHAO Zhong-peng;GAO Yu-wei;HUANG Geng
  

  1. 1. The Military Veterinary Institute, Quartermaster University of PLA,Changchun 130062, China;2. College of Animal Science and Technology,Shanxi Agricultural University,Taigu 030801 ,China;3 College of AnimalScience and Technology,Shandong Agricultural University,Taian 271018,China
  • Received:1900-01-01 Revised:1900-01-01 Online:2006-01-25 Published:2006-01-25

摘要: 以构建的真核表达载体pVAXLPH、pVAXLPF和pVAXLPN为基因疫苗,分组进行了免疫小鼠试验,对免疫鼠体内免疫应答水平进行了检测。结果显示: 所构建的基因疫苗可以诱导小鼠产生特异性免疫应答反应,pVAXLPH+pVAXLPF+pVAXLPN 3个基因混合免疫小鼠诱导产生了较强的体液免疫和细胞免疫应答,免疫3次后血清中抗CDV ELISA抗体效价为0.332,而免疫前为0.158;抗CDV中和抗体效价为1∶(4~16);CD4+T/CD8+T比值为2.05±0.38,而对照组为1.99±0.56;免疫小鼠脾细胞对CDVLP及ConA刺激的增殖反应值分别为0.384和0.356。基因疫苗免疫犬试验中,进行了单用基因疫苗免疫和基因疫苗与CDV弱毒疫苗联合免疫效果的比较研究。结果显示,基因疫苗免疫3次后,血清中抗CDV ELISA抗体效价为0.296,抗CDV中和抗体效价为1∶(8~32)。基因疫苗免疫2次,再使用弱毒疫苗加强免疫1次,血清中抗CDV ELISA抗体效价为0.433,抗CDV中和抗体效价为1∶(16~64)。

关键词: 犬瘟热, 基因疫苗, 犬瘟热病毒H基因, 犬瘟热病毒F基因, 犬瘟热病毒N基因

Abstract: Firstly,the mice were immuned with the expression plasmids by intramuscular injection. The first group was inoculated with pVAXLPH, the second group was inoculated with pVAXLPF, the third group was inoculated with pVAXLPH and pVAXLPF, the fourth group was inoculated with pVAXLPH, pVAXLPF and pVAXLPN, the fifth group was inoculated with empty vector DNA pVAX1 as negative control, and the sixth was inoculated with attenuated CDV vaccine as positive control. A total of three inoculations were performed at biweekly intervals. Indirect ELISA, neutralization and lymphocyte transformation assays were employed to determine the immunological response. As a result, the mice inoculated with these plasmids developed humoral and cellular immune responses against CDV. pVAXLPN did induce cell-mediated immunity, at high level. Tow weeks after the last injection ,the ELISA titers against CDV of the fourth group is 0.332, and SN titers against CDV of the fourth group is 1∶(4-16), the OD570 of lympho-spleencytes proliferation against CDV and ConA stimulation of the the fourth group is 0.384 and 0.356, respectively, the results of CD4+/CD8+ of the the fourth group is 2.05±0.38.Secondly, twenty 45-60 day-old CDV seronegative dogs were divided into four groups. All dogs in each group were immunized for 3 times. The first group was injected with a mixture of 200 μg of all the three plasmids containing the H, F and N gene, three times at biweekly intervals, the second group was injected with a mixture of 200 μg of all the three plasmids two times and with attenuated CDV vaccine once, the third group were injected with pVAX1 plasmid as negative control, and the fourth group was injected with attenuated CDV vaccine as positive control. Indirect ELISA, neutralization and lymphocyte transformation assays were employed to determine the immunological response. Two weeks after the last injection,the ELISA titers and SN titers against CDV of the first group is 0.296 and 1∶(8-32), respectively ;And the ELISA titers and SN titers against CDV of the second group is 0.433 and 1∶(16-64), respectively. As a result, the dogs inoculated with these plasmids developed humoral and cellular immune responses against CDV. The induced immune response in second group was higher than that in the first group.

Key words: CDV, DNA vaccine, CDV H, CDV F, CDV N